Literature DB >> 29036402

Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.

Scott W Woods1, Albert R Powers1, Jerome H Taylor2,3, Charlie A Davidson1,4,5, Jason K Johannesen1, Jean Addington6, Diana O Perkins7, Carrie E Bearden8,9, Kristin S Cadenhead10, Tyrone D Cannon11,12, Barbara A Cornblatt13, Larry J Seidman14, Ming T Tsuang10,14, Elaine F Walker4,5, Thomas H McGlashan1.   

Abstract

More than 20 years after the clinical high risk syndrome for psychosis (CHR) was first articulated, it remains controversial whether the CHR syndrome predicts onset of psychosis with diagnostic specificity or predicts pluripotential diagnostic outcomes. Recently, analyses of observational studies, however, have suggested that the CHR syndrome is not pluripotential for emergent diagnostic outcomes. The present report conducted additional analyses in previously reported samples to determine (1) whether comorbid disorders were more likely to persist in CHR patients compared to a comparison group of patients who responded to CHR recruitment efforts but did not meet criteria, termed help-seeking comparison subjects (HSC); and (2) whether clinically defined pluripotential CHR subgroups could be identified. All data were derived from 2 multisite studies in which DSM-IV structured diagnostic interviews were conducted at baseline and at 6-month intervals. Across samples we observed persistence of any nonpsychotic disorder in 80/147 CHR cases (54.4%) and in 48/84 HSC cases (57.1%, n.s.). Findings with persistence of anxiety, depressive, and bipolar disorders considered separately were similar. Efforts to discover pluripotential CHR subgroups were unsuccessful. These findings add additional support to the view that the CHR syndrome is not pluripotential for predicting various diagnostic outcomes but rather is specific for predicting emergent psychosis.

Entities:  

Mesh:

Year:  2018        PMID: 29036402      PMCID: PMC5814797          DOI: 10.1093/schbul/sbx138

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  74 in total

1.  Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Authors:  Jadon R Webb; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert K Heinssen; Larry J Seidman; Sarah I Tarbox; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Bull       Date:  2015-09       Impact factor: 9.306

Review 2.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

3.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.

Authors:  Raimo K R Salokangas; Stephan Ruhrmann; Heinrich Graf von Reventlow; Markus Heinimaa; Tanja Svirskis; Tiina From; Sinikka Luutonen; Georg Juckel; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Frauke Schultze-Lutter; Joachim Klosterkötter
Journal:  Schizophr Res       Date:  2012-03-31       Impact factor: 4.939

5.  Reliability and validity of the Comprehensive Assessment of the At Risk Mental State, Italian version (CAARMS-I).

Authors:  P Fusar-Poli; R Hobson; M Raduelli; U Balottin
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  The Clinical High-Risk State for Psychosis (CHR-P), Version II.

Authors:  Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2017-01       Impact factor: 9.306

7.  Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort.

Authors:  Kristin S Cadenhead; Jean Addington; Tyrone Cannon; Barbara Cornblatt; Thomas McGlashan; Diana Perkins; Larry Seidman; Ming Tsuang; Elaine Walker; Scott Woods; Robert Heinssen
Journal:  Early Interv Psychiatry       Date:  2010-08       Impact factor: 2.732

Review 8.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

9.  Early traumatic experiences in those at clinical high risk for psychosis.

Authors:  Jean Addington; Jacqueline Stowkowy; Kristin S Cadenhead; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon
Journal:  Early Interv Psychiatry       Date:  2013-01-24       Impact factor: 2.732

Review 10.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

View more
  19 in total

1.  Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project.

Authors:  Michele Poletti; Lorenzo Pelizza; Silvia Azzali; Federica Paterlini; Sara Garlassi; Ilaria Scazza; Luigi Rocco Chiri; Eva Gebhardt; Simona Pupo; Raballo Andrea
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-12-01       Impact factor: 4.785

2.  Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort.

Authors:  Jerome H Taylor; Nana Asabere; Monica E Calkins; Tyler M Moore; Sunny X Tang; Rose Mary Xavier; Alison K Merikangas; Daniel H Wolf; Laura Almasy; Ruben C Gur; Raquel E Gur
Journal:  Schizophr Res       Date:  2019-12-26       Impact factor: 4.939

3.  Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis.

Authors:  Zachary B Millman; Caroline Roemer; Teresa Vargas; Jason Schiffman; Vijay A Mittal; James M Gold
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

4.  Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.

Authors:  Scott W Woods; Carrie E Bearden; Fred W Sabb; William S Stone; John Torous; Barbara A Cornblatt; Diana O Perkins; Kristin S Cadenhead; Jean Addington; Albert R Powers; Daniel H Mathalon; Monica E Calkins; Daniel H Wolf; Cheryl M Corcoran; Leslie E Horton; Vijay A Mittal; Jason Schiffman; Lauren M Ellman; Gregory P Strauss; Daniel Mamah; Jimmy Choi; Godfrey D Pearlson; Jai L Shah; Paolo Fusar-Poli; Celso Arango; Jesus Perez; Nikolaos Koutsouleris; Jijun Wang; Jun Soo Kwon; Barbara C Walsh; Thomas H McGlashan; Steven E Hyman; Raquel E Gur; Tyrone D Cannon; John M Kane; Alan Anticevic
Journal:  Schizophr Res       Date:  2020-05-10       Impact factor: 4.662

Review 5.  Can We Predict Psychosis Outside the Clinical High-Risk State? A Systematic Review of Non-Psychotic Risk Syndromes for Mental Disorders.

Authors:  Tae Young Lee; Junhee Lee; Minah Kim; Eugenie Choe; Jun Soo Kwon
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

6.  Onset and transition of and recovery from adverse development: Study methodology.

Authors:  Johanna T W Wigman; Gerdina H M Pijnenborg; Richard Bruggeman; Maarten Vos; Anita Wessels; Inez Oosterholt; Maaike Nauta; Renee Stelwagen; Lana Otto; Anniek Wester; Lex Wunderink; Esther Sportel; Nynke Boonstra
Journal:  Early Interv Psychiatry       Date:  2019-11-05       Impact factor: 2.732

7.  NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.

Authors:  B Nelson; G P Amminger; H P Yuen; C Markulev; S Lavoie; M R Schäfer; J A Hartmann; N Mossaheb; M Schlögelhofer; S Smesny; I B Hickie; G Berger; E Y H Chen; L de Haan; D H Nieman; M Nordentoft; A Riecher-Rössler; S Verma; A Thompson; A R Yung; P D McGorry
Journal:  NPJ Schizophr       Date:  2018-06-25

Review 8.  Psychosis Risk and Development: What Do We Know From Population-Based Studies?

Authors:  Eva Mennigen; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2019-12-20       Impact factor: 13.382

9.  Depression: An actionable outcome for those at clinical high-risk.

Authors:  Jean Addington; Megan S Farris; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; William S Stone; Matcheri Keshevan; Scott W Woods
Journal:  Schizophr Res       Date:  2020-10-29       Impact factor: 4.939

10.  Computerized Assessment of Psychosis Risk.

Authors:  Vijay A Mittal; Lauren M Ellman; Gregory P Strauss; Elaine F Walker; Philip R Corlett; Jason Schiffman; Scott W Woods; Albert R Powers; Steven M Silverstein; James A Waltz; Richard Zinbarg; Shuo Chen; Trevor Williams; Joshua Kenney; James M Gold
Journal:  J Psychiatr Brain Sci       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.